argenx SE – American Depositary Shares (NASDAQ:ARGX) has been assigned a consensus broker rating score of 1.00 (Strong Buy) from the four analysts that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.

Brokerages have set a 12 month consensus target price of $50.67 for the company and are predicting that the company will post ($0.38) earnings per share for the current quarter, according to Zacks. Zacks has also given argenx SE – American Depositary Shares an industry rank of 158 out of 265 based on the ratings given to its competitors.

Several research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of argenx SE – American Depositary Shares from a “buy” rating to a “hold” rating in a research note on Tuesday. Piper Jaffray Companies raised their target price on shares of argenx SE – American Depositary Shares to $100.00 and gave the company an “overweight” rating in a research note on Tuesday, December 19th. Finally, Wedbush reaffirmed an “outperform” rating and issued a $41.00 target price (up previously from $26.00) on shares of argenx SE – American Depositary Shares in a research note on Thursday, November 16th. They noted that the move was a valuation call.

Hedge funds and other institutional investors have recently modified their holdings of the company. Alyeska Investment Group L.P. boosted its stake in shares of argenx SE – American Depositary Shares by 1.8% in the 3rd quarter. Alyeska Investment Group L.P. now owns 121,313 shares of the company’s stock valued at $2,743,000 after purchasing an additional 2,167 shares during the last quarter. Franklin Resources Inc. bought a new position in argenx SE – American Depositary Shares during the 2nd quarter worth approximately $7,424,000. Artal Group S.A. bought a new position in argenx SE – American Depositary Shares during the 3rd quarter worth approximately $1,229,000. Pictet Asset Management Ltd. bought a new position in argenx SE – American Depositary Shares during the 3rd quarter worth approximately $11,812,000. Finally, FMR LLC bought a new position in argenx SE – American Depositary Shares during the 2nd quarter worth approximately $15,990,000. 21.59% of the stock is currently owned by institutional investors.

Shares of argenx SE – American Depositary Shares (ARGX) traded down $2.64 during midday trading on Friday, hitting $59.79. 164,300 shares of the stock traded hands, compared to its average volume of 119,133. argenx SE – American Depositary Shares has a one year low of $17.33 and a one year high of $69.26.

TRADEMARK VIOLATION NOTICE: “Zacks: argenx SE – American Depositary Shares (ARGX) Given $50.67 Average Price Target by Brokerages” was first posted by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/01/05/zacks-argenx-se-american-depositary-shares-argx-given-50-67-average-price-target-by-brokerages.html.

argenx SE – American Depositary Shares Company Profile

argenx SE, a clinical-stage biopharmaceutical company, focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company’s lead clinical stage product candidates include ARGX-113, a product in Phase 2 clinical trials for the treatment of autoimmune diseases, including myasthenia gravis and immune thrombocytopenia; and ARGX-110, which is in Phase 1/2 clinical trials for the treatment of hematological cancers, such as T-cell lymphoma, acute myeloid leukemia, and myelodysplastic syndrome.

Get a free copy of the Zacks research report on argenx SE – American Depositary Shares (ARGX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for argenx SE - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for argenx SE - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.